Notably, dysregulation of PADI2 has also been linked to promoting the pathogenesis and progression of cancer [9], including breast [10], prostate [11], and colorectal [12] cancer, and has also been suggested to promote tumor metastasis. Here, PADI2 is linked to neoplasm.